Results 251 to 260 of about 111,907 (307)
Focusing on the Apolipoprotein M-Mitophagy Axis: A Mechanism for Renal Protection in Diabetic Nephropathy. [PDF]
J Diabetes ResChen T, Yang M.
europepmc +1 more source
Cafestol ameliorates diabetic nephropathy via Keap1-Nrf2 axis activation: A novel renoprotective mechanism independent of glycemic control. [PDF]
PLoS OneSinan NA, Almujaydil MS.
europepmc +1 more source
Predictive value of biomarkers for tubulointerstitial and glomerular interactions in diabetic nephropathy. [PDF]
World J NephrolAlamilla-Sanchez M +3 more
europepmc +1 more source
Copper metabolism-related biomarkers and therapeutic targets for diabetic nephropathy. [PDF]
PeerJYan Q +11 more
europepmc +1 more source
Manufacturing and clinical applications of non‐CAR‐T immune effector cells
Transfusion, EarlyView.
Thane Kubik +2 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Cornerstone, 2003
As the epidemic of diabetes spreads so does the number of patients at risk for developing diabetic nephropathy, which occurs in 20% to 40% of all diabetic patients. Indeed, diabetes is the most common cause of end-stage renal disease (ESRD) in the United States, accounting for > 40% of patients starting renal replacement therapy each year ...
Mark E, Molitch +5 more
openaire +4 more sources
As the epidemic of diabetes spreads so does the number of patients at risk for developing diabetic nephropathy, which occurs in 20% to 40% of all diabetic patients. Indeed, diabetes is the most common cause of end-stage renal disease (ESRD) in the United States, accounting for > 40% of patients starting renal replacement therapy each year ...
Mark E, Molitch +5 more
openaire +4 more sources
Medical Clinics of North America, 1997
Diabetic nephropathy accounts for almost a third of all causes of ESRD. Microalbuminuria screening among diabetics can offer early detection of incipient nephropathy. Aggressive treatment with ACE inhibitors may delay the onset of overt renal failure or delay its progression.
CASTELLINO, Pietro +2 more
openaire +6 more sources
Diabetic nephropathy accounts for almost a third of all causes of ESRD. Microalbuminuria screening among diabetics can offer early detection of incipient nephropathy. Aggressive treatment with ACE inhibitors may delay the onset of overt renal failure or delay its progression.
CASTELLINO, Pietro +2 more
openaire +6 more sources
Current Opinion in Internal Medicine, 2003
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
M Luiza, Caramori, Michael, Mauer
openaire +2 more sources
Diabetic nephropathy is the single most common disorder leading to renal failure. Its annual incidence has more than doubled in the past decade to reach 44% of all end-stage renal disease, despite recent therapeutic advances. Thus, research into diabetic nephropathy pathophysiology that could lead to new treatment approaches is urgently needed and this
M Luiza, Caramori, Michael, Mauer
openaire +2 more sources
Best Practice & Research Clinical Endocrinology & Metabolism, 1999
Diabetic nephropathy remains a leading cause of end-stage renal disease (ESRD) in western societies, accounting for over one-third of all patients beginning renal replacement therapy. Patients with Type 2 diabetes comprise the largest and fastest-growing single disease group requiring renal support therapy.
H A, Ibrahim, J P, Vora
openaire +4 more sources
Diabetic nephropathy remains a leading cause of end-stage renal disease (ESRD) in western societies, accounting for over one-third of all patients beginning renal replacement therapy. Patients with Type 2 diabetes comprise the largest and fastest-growing single disease group requiring renal support therapy.
H A, Ibrahim, J P, Vora
openaire +4 more sources
Disease-a-Month, 1993
Diabetic nephropathy occurs in approximately 35% of all diabetic patients, both insulin and non-insulin dependent. It accounts for the largest proportion increase of all diseases as a cause for endstage renal disease in the United States. Certain populations, i.e., Pima Indians and Mexican and black Americans, have a higher propensity for developing ...
G L, Bakris, J H, Stein
openaire +2 more sources
Diabetic nephropathy occurs in approximately 35% of all diabetic patients, both insulin and non-insulin dependent. It accounts for the largest proportion increase of all diseases as a cause for endstage renal disease in the United States. Certain populations, i.e., Pima Indians and Mexican and black Americans, have a higher propensity for developing ...
G L, Bakris, J H, Stein
openaire +2 more sources